Loading...
The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after allo-HSCT is a devastating complication with limited therapeutic options. We aimed to assess the efficacy and safety of mesenchymal stem cells (MSCs) in BOS after allo-HSCT. METHODS: This multicenter prospective cohort study enrolled 81 allo-...
Na minha lista:
| Udgivet i: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945279/ https://ncbi.nlm.nih.gov/pubmed/31668569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.09.039 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|